HomeCompareCHNVF vs MRK

CHNVF vs MRK: Dividend Comparison 2026

CHNVF yields 10526.32% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CHNVF wins by $91421458538285344.00M in total portfolio value
10 years
CHNVF
CHNVF
● Live price
10526.32%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$91421458538285344.00M
Annual income
$89,744,322,218,307,970,000,000.00
Full CHNVF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CHNVF vs MRK

📍 CHNVF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCHNVFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CHNVF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CHNVF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CHNVF
Annual income on $10K today (after 15% tax)
$894,736.84/yr
After 10yr DRIP, annual income (after tax)
$76,282,673,885,561,770,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, CHNVF beats the other by $76,282,673,885,561,770,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CHNVF + MRK for your $10,000?

CHNVF: 50%MRK: 50%
100% MRK50/50100% CHNVF
Portfolio after 10yr
$45710729269142672.00M
Annual income
$44,872,161,109,153,986,000,000.00/yr
Blended yield
98.17%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CHNVF
No analyst data
Altman Z
1.5
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CHNVF buys
0
MRK buys
0
No recent congressional trades found for CHNVF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCHNVFMRK
Forward yield10526.32%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$91421458538285344.00M$56.8K
Annual income after 10y$89,744,322,218,307,970,000,000.00$9,798.13
Total dividends collected$91309952364754128.00M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CHNVF vs MRK ($10,000, DRIP)

YearCHNVF PortfolioCHNVF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$1,063,332$1,052,631.58$11,206$366.19+$1.05MCHNVF
2$105,744,905$104,607,140.08$12,650$502.35+$105.73MCHNVF
3$9,835,430,757$9,722,283,708.79$14,407$694.19+$9835.42MCHNVF
4$855,644,041,989$845,120,131,078.84$16,585$967.82+$855644.03MCHNVF
5$69,627,827,846,009$68,712,288,721,080.95$19,342$1,363.89+$69627827.83MCHNVF
6$5,300,152,192,813,391$5,225,650,417,018,161.00$22,913$1,947.19+$5300152192.79MCHNVF
7$377,430,657,448,967,200$371,759,494,602,656,830.00$27,662$2,823.89+$377430657448.94MCHNVF
8$25,145,413,383,015,215,000$24,741,562,579,544,820,000.00$34,159$4,173.35+$25145413383015.18MCHNVF
9$1,567,417,121,474,185,500,000$1,540,511,529,154,359,300,000.00$43,337$6,308.80+$1567417121474185.50MCHNVF
10$91,421,458,538,285,340,000,000$89,744,322,218,307,970,000,000.00$56,776$9,798.13+$91421458538285344.00MCHNVF

CHNVF vs MRK: Complete Analysis 2026

CHNVFStock

China Youzan Limited, an investment holding company, provides online and offline e-commerce solutions in the People's Republic of China, Japan, and Canada. The company operates through five segments: General Trading, Third Party Payment Services, Onecomm, Merchant Services, and Others. It trades in watches and other good; sells integrated smart point of sales devices; and offers third party payment and related consultancy services, as well as third party payment management services. The company also offers an e-commerce platform with a variety of Software as a Service products and comprehensive services. In addition, it provides information system maintenance and development services; catering services; management services; wholesale and retail internet information services; restaurant management and retail solutions; and factoring and guarantee services, as well as operation services for merchants and retail solutions for beauty industries. The company was formerly known as China Innovationpay Group Limited and changed its name to China Youzan Limited in May 2018. China Youzan Limited was incorporated in 1999 and is based in Wanchai, Hong Kong.

Full CHNVF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CHNVF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CHNVF vs SCHDCHNVF vs JEPICHNVF vs OCHNVF vs KOCHNVF vs MAINCHNVF vs JNJCHNVF vs ABBVCHNVF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.